Abstract
BackgroundTumor necrosis factor (TNF) is a critical effector and a therapeutic target in rheumatoid arthritis (RA). TNF inhibitors are also preferably used in the treatment of severe autoimmune uveitis, however,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
